Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 202 participants.
Also called NCT03067688
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 202 participants
- Sponsor
- Registry
-
NCT03067688
-
- Other papers using this trial's data
- Efficacy and safety of co-administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT03067688. Randomized; double masking; primary purpose treatment. Start 2017-04-11 (actual); primary completion 2018-03-27 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia
- Condition
- Hypertension
- Condition
- Hyperlipidemia
- Intervention (Drug)
- Temisartan+Amlodipine+Rosuvastatin (Combination drug)
- Intervention (Drug)
- Temisartan+Amlodipine
- Intervention (Drug)
- Temisartan+Rosuvastatin
- Lead sponsor
- Yuhan Corporation
Record details
- Record id
cardio:ct-nct03067688- Content hash
0aeac6c2826f428b5e4e7add4f07123c78fc603628da58b4eca3c83af9cb8368